INS and Alzheimer disease: At the molecular level, these conditions share common features such as chronic inflammation and mitochondrial dysfunction, leading some researchers to propose “Type 3 Diabetes” as a classification for AD cases with prominent insulin signaling disruption (la Monte and Wands 2008; Kciuk et al. 2024).